Direct-to-Patient shipment: Time to Stop and Think
Eric Schnitzer presents how Direct-to-Patient shipments were managed during COVID, the benefits and limitations of current solutions, and what the future of DtP should look like.
Speakers
![Eric Schnitzer image](https://www.calyx.ai/wp-content/uploads/2021/10/CALYX-20-Headshots-EricSchnitzer-FINAL_v1-300x300.jpg)
Eric Schnitzer
Product Director, Calyx
Eric is a Product Director at Calyx with over 15 years of experience in eClinical technologies for clinical trials as well as for other healthcare products. He has a background working with various IRT solutions and with clinical supply groups from many Pharmaceutical and Biotech companies.